Marker Therapeutics, Inc.

Tagged: webcast

Marker Therapeutics Provides Business and Clinical Update

Company to host business update call and webcast today at 5:00 p.m. EDT

Read More

Marker Therapeutics to Host Business Update Conference Call and Webcast on Thursday, March 28th

Marker Therapeutics announces business update conference call and webcast on Thursday, March 28th.

Read More

TapImmune to Present at Two Upcoming Investor Conferences

Peter L. Hoang will be presenting at the 2018 Cantor Global Healthcare Conference and the Sachs Associates 18th Annual Biotech in Europe Forum. Webcast will be available for both events.

Read More

TapImmune To Present at 2018 Janney Healthcare Conference

Peter L. Hoang will be presenting at the 2018 Janney Healthcare Conference.

Read More

TapImmune to Participate at Two Upcoming Industry Conferences

Peter L. Hoang will be participating in two industry conferences next week.

Read More

TapImmune Announces Pricing of $70 Million Private Placement

TapImmune today announced that it has entered into security purchase agreements with certain institutional and accredited investors in connection with a private placement of its equity securities. The private placement will be led by New Enterprise Associates (NEA) with participation from Aisling Capital and Perceptive Advisors, among other new and existing investors.

Read More

TapImmune to Present at the Jefferies 2018 Global Healthcare Conference

TapImmune today announced that its President and CEO, Peter L. Hoang, will present at the Jefferies 2018 Global Healthcare Conference taking place June 5-8, 2018, in New York City.

Read More

TapImmune to Present at 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum

TapImmune today announced that its President and CEO, Peter Hoang, will participate in a panel discussion and give a company presentation at the 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum, held June 1, 2018, at the Waldorf Astoria Chicago Hotel.

Read More

TapImmune to Host Investor Webinar on Thursday, May 24th to Discuss Proposed Merger with Marker Therapeutics and Its Transformational T Cell Therapy Platform

TapImmune Inc. (NASDAQ: TPIV) announced today that Peter Hoang, President and CEO, will host a video webinar and slide presentation to discuss the details of the proposed merger with Marker Therapeutics, Inc., on Thursday, May 24, 2018, at 4:05 p.m. EST. The webinar will be followed by a live Q&A session.

Read More

TapImmune Inc. Presentation Now Available for On-Demand Viewing

You can now view the presentation from last Thursday’s Virtual Investor Conference call.

Read More